期刊文献+

外周血C3,C4与慢性荨麻疹患者病情的相关性 被引量:11

Investigate Chronic Urticaria Patient’s Condition Correlating to C3, C4 of Peripheral Blood
在线阅读 下载PDF
导出
摘要 目的探讨慢性荨麻疹(chronicurticaria,CU)患者外周血C3,C4水平与病情的相关性。方法采用免疫比浊法检测19例急性荨麻疹(acuteurticaria,AU)、146例CU患者的外周血C3,C4及IgG水平,并以20例健康人为对照。并通过荨麻疹活动评分(UAS)对165例荨麻疹患者的病情进行评分。结果 AU,CU患者外周血的C3,C4及IgG水平差异均无统计学意义(P均>0.05)。男女性CU患者外周血的C3,C4及IgG水平差异均无统计学意义(P均>0.05)。32例CU患者IgG水平高于正常值(IgG>17g/L),与C3,C4水平呈负相关(P<0.05)。UAS与荨麻疹外周血的C3,C4及IgG水平相关性差,差异无统计学意义(P均>0.05),但与IgG水平升高CU患者的C3,C4水平呈负相关,差异有统计学意义(P<0.05)。结论外周血C3,C4水平可以反应IgG水平升高的CU患者的病情。 Objective To investigate the expression of C3, C4 and lgG in peripheral blood of patients with chronic urti- caria(CU) and its eorrelationship with CU patients' severity. Methods The expression of C3, C4 amt IgG was measured by Immune Turbidimetry in 19 patients with acute urticaria(AU) , 146 patients with CU and 20 normal controls. The severity of 165 patients with uriearia was evaluated by Urticaria Activity Score (UAS). Results There were no statistically difference in the expression of C3, C4 and lgG between AU and CU patients (P 〉 0.05 ) , between male and female CU patients respectively( P 〉 0.05 ). The expression of IgG was higher than normal control( IgG 〉 17g/L) in 32 CU patients, and showed negative correlation with the expression of C3 and C4 (P 〈 0.05 ). UAS was poor relation to the expression of C3, C4 and IgG in urticaria patient's peripheral blood, but was negative con'elation to the levels of C3, C4 in CU patients whose expression of lgG was higher than normal control( P 〈 0.05 ). Conclusion The expression of C3, C4 could respond to the severity of CU patients whose expression of IgG is higher than normal control.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2013年第1期26-28,共3页 The Chinese Journal of Dermatovenereology
关键词 慢性荨麻疹(CU) C3 C4 荨麻疹活动评分(UAS) Chronic urticaria(CU) C3 C4 Urticaria activity score (UAS)
  • 相关文献

参考文献12

  • 1Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2) LEN/ EDF/WAO guideline : definition, classification anddiagnosis of urticaria[J]. Allergy, 2009, 64(10) :1417 - 1426.
  • 2Greaves M. Chronic urticaria[J]. J Allergy Clin Immunol, 2000,105 (4) :664 -672.
  • 3Kaplan AP, Greaves M. Pathogenesis of chronic urticaria [J]. Clin Exp Allergy, 2009, 39(6) :777 -787.
  • 4Miescher SM, Horn MP, Pachlopnik JM, et al. Natural anti-Fcepsilon- RIalpha autoantibodies isolated from healthy donors and hronic idiopathic urticaria patients reveal a restricted repertoire and autoreactivity on human basophils [ J ]. Hum Antibodies, 2001,10 ( 3-4 ) : 119 - 126.
  • 5Kikuehi Y, Kaplan A. A role for C5a in augmenting IgG dependent histamine release from basophils in chronic urticaria [ J ]. J Allergy Clin Immunol, 2002, 109 ( 1 ) : 114 - 118.
  • 6甘慧,杨军,孙萍,王全立.人类补体C3研究进展[J].国外医学(临床生物化学与检验学分册),2004,25(6):519-521. 被引量:26
  • 7Zamiri M, Jury SC, Dawe SR, et al. Reactivity to autologous serum skin test and relationship with complement levels in chronic idiopathic urticaria and angio-oedema[ J]. Clinical and Experimental Dermatology, 2009,34(5):587 -590.
  • 8Barnun S, Jones J, Ladner U, et al. Chronic complement C3 gene expression in the CNS of transgenic mice with as trocyte-targeted interleukin-6 expression [ J ]. GLIA, 1996, 18 ( 2 ) : 107 - 117.
  • 9Katz Y, Nadiv O, Papoport M, et al. IL-17 regulates gene expression and protein synthesis of the complement system, C3 and factor B, in skin fibroblasts[J]. Clin Exp hnmunol, 2000, 120( 1 ) :22 - 29.
  • 10Andrews E, Feldhoff P, Feldhoff R, et al. Comparative effects of cytokines and cytokine combinations on complement component C3 secretion by HepG2 cells[Jl. Cytokine, 2003, 23(6) :164 - 169.

二级参考文献13

  • 1Lambris JD, Reid KB, Volanakis JE. The evolution,structure,biology and pathophysiology of complement. Immunol Today, 1999, 20(5): 207-211.
  • 2Mollnes TE, Song WC, Lambris JD. Complement in inflammatory tissue damage and disease. Trends Immunol, 2002, 23(2): 61-64.
  • 3Sassi F, Bejaoui M, Ayed K. A congenital deficiency of the C3 fraction of complement. A familial study. Tunis Med,2003,81(5): 354-358.
  • 4Mizuno Y, Hara T. C3 deficiency. Ryoikibetsu Shokogun Shirizu,2000,32: 196-198.
  • 5Negi VS, Aggarwal A, Dayal R, et al. Complement degradation product C3d in urine: marker of lupus nephritis. J Rheumatol, 2000, 27(2): 380-383.
  • 6Ross TM, Xu Y, Bright RA, et al. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat Immunol, 2000, 1(2): 127-131.
  • 7Abelseth TK, Stensvag K, Espelid S, et al. The spotted wolffish (Anarhichas minor Olafsen) complement component C3: isolation,characterisation and tissue distribution. Fish Shellfish Immunol, 2003, 15(1): 13-27.
  • 8Sahu A, Morikis D, Lambris JD. Compstatin,a peptide inhibitor of complement,exhibits species-specific binding to complement component C3. Mol Immunol, 2003, 39(10): 557-566.
  • 9Nagar B, Jones RG, Diefenbach RJ, et al. X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. Science, 1998, 280(5367): 1277-1281.
  • 10Ekdahl KN, Nilsson B. Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets.J Immunol, 1999, 162(12): 7426-7433.

共引文献25

同被引文献151

  • 1李宏军,桂金萍.温阳法治疗慢性荨麻疹刍议[J].中医杂志,2011,52(S1):38-39. 被引量:2
  • 2林利虹,万慧,李少波,杜鹃.氮卓斯汀、孟鲁司特钠配合左西替利嗪治疗慢性荨麻疹的临床研究[J].中国生化药物杂志,2014,34(3):148-150. 被引量:14
  • 3孙仁山,陈晓红,冉新泽,程天民,刘荣卿.慢性特发性荨麻疹患者外周血单个核细胞分泌IFN-γ和IL-4水平检测及意义[J].中国皮肤性病学杂志,2005,19(3):149-150. 被引量:14
  • 4Susan MM. Potential role of histamine releasing factor (HRF) as a therapeutic target for treating asthma and allergy[ J]. J Asthma Allergy, 2012,2012(5) :51 -59.
  • 5Zuberbier T. A Summary of the new international EAAC1/GALEN/EDF/ WAO guiddines in urticaria[J]. World Allergy Organ J,2012 ,5(1) :1 -5.
  • 6KimM, MaengJ, LeeK. Dimerization of TCTP and its clinical implica- tions for allergy [ J ]. Biochimie,2013,95 (4) :659 - 666.
  • 7Yuko Kawakanfi, Toshiaki Kawakami, Jun-ichi Kashiwakura, et al. Most highly cytokinergic lgEs have polyreactivity to autoantigens[ J ]. Allergy Asthma lmmunol Res,2012,4(6) :332 -340.
  • 8Ando T,Kashiwakura J, Kawakami Y, et al. Histamine releasing factor (HRF) in asthma and atopic dermatitis[ J ]. J Immunol,2012,188 : 177.
  • 9Zuberbier T,Asero R,Bindslev-Jensen C,et al.EAACI/GA(2)LEN/EDF/WAO guideline:definition,classification and diagnosis of urticaria[J].Allergy,2009,64(10):1417-1426.
  • 10Kasperska-Zajac A,Sztylc J,Machura E,et al.Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients[J].Clin Exp Allergy,2011,41(10):1386-1391.

引证文献11

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部